ESC Premium Access

Stroke and Atherosclerosis – From Risk Evaluation to Treatment

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session type: Advances in Science
Date: 30 August 2020
Time: 11:05 - 11:40

Congress Session

3 presentations in this session

Differential impact of life-long lower LDL-C levels on ischaemic stroke subtypes and coronary heart disease risk among 1 million individuals

Speaker: Associate Professor J. Hopewell (Oxford, GB)
Thumbnail

Cardiac troponin I and incident stroke in European cohorts - insights from the BiomarCaRE project

Speaker: Doctor S. Camen (Hamburg, DE)
Thumbnail

Efficacy of rivaroxaban compared to standard of care in preventing ischemic stroke in adults with coronary or peripheral vascular disease: an integrated analysis using patient-level data

Speaker: Doctor E. Barnathan (Spring House, US)
Thumbnail

3 speakers from this session

Associate Professor Jemma C Hopewell

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Stephan Camen

University Heart and Vascular Center Hamburg, Hamburg (Germany)
0 follower

Doctor Elliot Barnathan

Janssen R and D LLC, Spring House (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk